1. Home
  2. Volume 25 Number 3, October 2025
  3. MAHDANI

Microbiological and urinalysis assessment of UTIs in COVID-19 patients at Dr. Zainoel Abidin Hospital, Banda Aceh.

WILDA MAHDANI, MUHAMMAD SHADIQUL ZIKRI, SAMINAN SAMINAN

Abstract


One of the secondary infections observed among COVID-19 patients is a Urinary Tract Infection (UTI). The presence of bacteria and fungi causes UTI, which can certainly occur after a urine culture. Urinalysis is one of the critical examinations to diagnose UTIs and assess functional disorders in the urinary tract. This study examines the characteristics of microbes isolated from urine specimens and urinalysis results in COVID-19 patients at Dr. Zainoel Abidin Hospital, Banda Aceh.  This observational analytic study used secondary data from urine culture and urinalysis results of COVID-19 patients by implementing the total sampling technique. This study involved 110 urine culture data from confirmed COVID-19 patients. Comparative analysis of parameters between positive and negative urine culture groups with urinalysis results using categorical variables through the Chi-square test and Fisher's Exact test. The findings suggest that Escherichia coli, Enterococcus spp., and Candida spp. are the predominant uropathogens in COVID-19 patients, with urinalysis frequently indicating leukocytosis as a marker of urinary tract involvement. Urine culture is the gold standard for quantitatively diagnosing UTIs by determining bacterial density and identifying specific pathogens. Urinalysis, which checks for leukocytes in the urine, can support these results.

Keywords


COVID-19, urinalysis, urinary tract infection, urine culture

References


REFERENCE

Ciotti, M.; Ciccozzi, M.; Terrinoni, A.; Jiang, W.-C.; Wang, C.-B.; and Bernardini, S. 2020. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57(6), 365–388. DOI: 10.1080/10408363.2020.1783198.

WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/europe/emergencies/situations/covid-19

Hallak, J.; Teixeira, T.A.; Bernardes, F.S.; Carneiro, F.; Duarte, S.A.S.; Pariz, J.R.; Esteves, S.C.; Kallas, E.; and Saldiva, P.H.N. 2021. SARS‐CoV‐2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID‐19 pandemic. Andrology 9(1) 73–79. DOI: 10.1111/andr.12896.

Surendra, H.; Paramita, D.; Arista, N.N.; Putri, A.I.; Siregar, A.A.; Puspaningrum, E.; Rosylin, L.; Gardera, D.; Girianna, M.; and Elyazar, I.R.F. 2023. Geographical variations and district-level factors associated with COVID-19 mortality in Indonesia: a nationwide ecological study. BMC Public Health 23(1) 103. DOI: 10.1186/s12889-023-15015-0.

Banda Aceh City Health Office. Profil Kesehatan Kota Banda Aceh Tahun 2023 (Banda Aceh City Health Profile 2023). https://dinkes.bandaacehkota.go.id/wp-content/uploads/sites/36/2025/05/profilkes_kota_banda_aceh_2023_compressed.pdf

Silvalila, M.; Sari, S.; and Huzaifi, N. 2025. Evaluasi tingkat kematian pasien COVID-19 tahun 2021 di RSUD Dr. Zainoel Abidin Banda Aceh. J. Med. Sci. 6(1) 71–80. DOI: 10.55572/jms.v6i1.214.

Li, X.; Geng, M.; Peng, Y.; Meng, L.; and Lu, S. 2020. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 10(2) 102–108. DOI: 10.1016/j.jpha.2020.03.001.

Langford, B.J.; So, M.; Raybardhan, S.; Leung, V.; Westwood, D.; MacFadden, D.R.; Soucy, J.-P.R.; and Daneman, N. 2020. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin. Microbiol. Infect. 26(12) 1622–1629. DOI: 10.1016/j.cmi.2020.07.016.

Bardi, T.; Pintado, V.; Gomez-Rojo, M.; Escudero-Sanchez, R.; Azzam Lopez, A.; Diez-Remesal, Y.; Martinez Castro, N.; Ruiz-Garbajosa, P.; and Pestaña, D. 2021. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur. J. Clin. Microbiol. Infect. Dis. 40(3) 495–502. DOI: 10.1007/s10096-020-04142-w.

Dąbrowska, P.; Bartoszewicz, M.; Bartoszewicz, K.; Kosel, J.; Stróż, S.; Ładny, J.R.; and Czaban, S.L. 2024. Catheter-associated urinary tract infections in critically Ill patients with COVID-19: a retrospective cohort study. Ther. Adv. Infect. Dis. 11 20499361241278218. DOI: 10.1177/20499361241278218.

Yang, X.; Li, X.; Qiu, S.; Liu, C.; Chen, S.; Xia, H.; Zeng, Y.; Shi, L.; Chen, J.; Zheng, J.; et al., 2024. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data. J. Infect. 89(1) 106183. DOI: 10.1016/j.jinf.2024.106183.

Daneshpajooh, A.; Mirzaei, M.; and Salehi-Pourmehr, H. 2024. Lower urinary tract symptoms in patients with COVID-19: results of a cross-sectional study. J. Urol. Surg. 11(2) 72–79. DOI: 10.4274/jus.galenos.2024.2023-12-6.

Chichirelo-Konstantynovych, K.; and Konstantynovych, T. 2023. P16 COVID-19 and urinary tract infection: the main manifestations and their management. JAC-Antimicrob. Resist. 5(Supplement_3) dlad077.020. DOI: 10.1093/jacamr/dlad077.020.

Liu, A.Q.; Choy, E.K.-H.; Chiu, P.K.-F.; Yee, C.-H.; Ng, C.-F.; and Teoh, J.Y.-C. 2024. High levels of incidental COVID-19 infection in emergency urology admissions: a propensity score-matched real world data analysis across surgical specialties. Viruses 16(9) 1402. DOI: 10.3390/v16091402.

Beahm, N.P.; Nicolle, L.E.; Bursey, A.; Smyth, D.J.; and Tsuyuki, R.T. 2017. The assessment and management of urinary tract infections in adults: Guidelines for pharmacists. Can. Pharm. J. Rev. Pharm. Can. 150(5) 298–305. DOI: 10.1177/1715163517723036.

Chun, T.T.S.; Ruan, X.; Ng, S.L.; Wong, H.L.; Ho, B.S.H.; Tsang, C.F.; Lai, T.C.T.; Ng, A.T.L.; Ma, W.K.; Lam, W.P.; et al. 2022. The diagnostic value of rapid urine test platform UF-5000 for suspected urinary tract infection at the emergency department. Front. Cell. Infect. Microbiol. 12 936854. DOI: 10.3389/fcimb.2022.936854.

Najeeb, S.; Munir, T.; Rehman, S.; Hafiz, A.; Gilani, M.; and Latif, M. 2015. Comparison of urine dipstick test with conventional urine culture in diagnosis of urinary tract infection. 25(2) 108-110.

Hernández-Hernández, D.; Ortega-González, Y.; Padilla-Fernández, B.; Gutiérrez-Hernández, P.R.; and Castro-Díaz, D.M. 2023. Management of acute cystitis in the era of COVID-19. Curr. Bladder Dysfunct. Rep. 18(1) 10–15. DOI: 10.1007/s11884-022-00677-0.

Moreland, R.B.; Brubaker, L.; Tinawi, L.; and Wolfe, A.J. 2025. Rapid and accurate testing for urinary tract infection: new clothes for the emperor. Clin. Microbiol. Rev. 38(1) e00129-24. DOI: 10.1128/cmr.00129-24.

Choi, M.H.; Kim, D.; Bae, H.G.; Kim, A.-R.; Lee, M.; Lee, K.; Lee, K.-R.; and Jeong, S.H. 2024. Predictive performance of urinalysis for urine culture results according to causative microorganisms: an integrated analysis with artificial intelligence. J. Clin. Microbiol. 62(10) e01175-24. DOI: 10.1128/jcm.01175-24.

Başer, A.; Yilmaz, A.; Başer, H.Y.; Özlülerden, Y.; and Zümrütbaş, A.E. 2020. Which patient should start empirical antibiotic treatment in urinary tract infection in emergency departments? Turk. J. Emerg. Med. 20(3) 111–117. DOI: 10.4103/2452-2473.290064.

Irvine, A.; Watt, J.; Kurth, M.J.; Lamont, J.; Fitzgerald, P.; and Ruddock, M. 2024. The Importance of Diagnostics in the treatment of urinary tract infections in the united kingdom. Res. Rep. Urol. 16 327–335. DOI: 10.2147/RRU.S483147.

Xu, R.; Deebel, N.; Casals, R.; Dutta, R.; and Mirzazadeh, M. 2021. A New Gold Rush: A review of current and developing diagnostic tools for urinary tract infections. Diagnostics 11(3) 479. DOI: 10.3390/diagnostics11030479.

Davies, N.G.; Klepac, P.; Liu, Y.; Prem, K.; Jit, M.; CMMID COVID-19 working group; Pearson, C.A.B.; Quilty, B.J.; Kucharski, A.J.; Gibbs, H.; et al. 2020. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat. Med. 26(8) 1205–1211. DOI: 10.1038/s41591-020-0962-9.

O’Driscoll, M.; Ribeiro Dos Santos, G.; Wang, L.; Cummings, D.A.T.; Azman, A.S.; Paireau, J.; Fontanet, A.; Cauchemez, S.; and Salje, H. 2021. Age-specific mortality and immunity patterns of SARS-CoV-2. Nature 590(7844) 140–145. DOI: 10.1038/s41586-020-2918-0.

Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. 2020. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395(10229), 1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.

Bienvenu, L.A.; Noonan, J.; Wang, X.; and Peter, K. 2020. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc. Res. 116(14), 2197–2206. DOI: 10.1093/cvr/cvaa284.

Klein, S.L.; Dhakal, S.; Ursin, R.L.; Deshpande, S.; Sandberg, K.; and Mauvais-Jarvis, F. 2020. Biological sex impacts COVID-19 outcomes. PLOS Pathog. 16(6), e1008570. DOI: 10.1371/journal.ppat.1008570.

Klein, S.L.; and Morgan, R. 2020. The impact of sex and gender on immunotherapy outcomes. Biol. Sex Differ. 11(1), 24. DOI: 10.1186/s13293-020-00301-y.

Stoian, M.; Azamfirei, L.; Andone, A.; Văsieșiu, A.-M.; Stîngaciu, A.; Huțanu, A.; Bândilă, S.R.; Dobru, D.; Manea, A.; and Stoian, A. 2025. Incidence and risk factors of secondary infections in critically Ill SARS-CoV-2 patients: a retrospective study in an intensive care unit. Biomedicines 13(6), 1333. DOI: 10.3390/biomedicines13061333.

Grasselli, G.; Pesenti, A.; and Cecconi, M. 2020. Critical care utilization for the COVID-19 outbreak in lombardy, italy: early experience and forecast during an emergency response. JAMA 323(16), 1545. DOI: 10.1001/jama.2020.4031.

Hernández, F.L.C.; Virguez, J.V.; Vesga, J.F.G.; Castellanos, M.L.; Beltrán, G.R.; Toquica, L.D.L.; Gomez, C.N.S.; Ríos, M.V.S.; Bolívar, Y.R.C.; and Sanchez, J.I.A. 2024. Effect of COVID-19 on infections associated with medical devices in critical care. BMC Infect. Dis. 24(1), 110. DOI: 10.1186/s12879-023-08934-1.

Karlsson, P.A.; Pärssinen, J.; Danielsson, E.A.; Fatsis-Kavalopoulos, N.; Frithiof, R.; Hultström, M.; Lipcsey, M.; Järhult, J.D.; and Wang, H. 2023. Antibiotic use during coronavirus disease 2019 intensive care unit shape multidrug resistance bacteriuria: A Swedish longitudinal prospective study. Front. Med. 10, 1087446. DOI: 10.3389/fmed.2023.1087446.

Setiawan, E.; Felix, H.; and Setiadi, A.P. 2017. Analysis of the utilization and cost of antibiotics at an intensive care unit in Surabaya. Pharmaciana 7(2) 217. DOI: 10.12928/pharmaciana.v7i2.6767.

Mareș, C.; Petca, R.-C.; Petca, A.; Popescu, R.-I.; and Jinga, V. 2022. Does the COVID pandemic modify the antibiotic resistance of uropathogens in female patients? a new storm? Antibiotics 11(3) 376. DOI: 10.3390/antibiotics11030376.

Shiyadeh, Z.S.; Farahyar, S.; Vahedi Larijani, L.; Beardsley, J.; Nouri, N.; Mahmoudi, S.; Roudbar Mohammadi, S.; Rodrigues, C.F.; and Roudbary, M. 2024. Hospitalized COVID-19 patients with urinary tract infection in iran: candida species distribution and antifungal susceptibility patterns. Antibiotics 13(7) 633. DOI: 10.3390/antibiotics13070633.

Cronyn, V.; Howard, J.; Chiang, L.; Le, L.; Tims-Cook, Z.; and Gertz, A.M. 2021. Trichosporon asahii urinary tract infection in a patient with severe COVID-19. Case Rep. Infect. Dis. 2021 1–6. DOI: 10.1155/2021/6841393.

Shetty, S.; Agrawal, U.; Kruthi, M.; Kardale, A.; Rodrigues, C.; Joshi, V.; Hegde, A.; and Sunavala, A. 2022. P133 Post-COVID-19 recurrent fungal urinary tract infections: A case series. Med. Mycol. 60(Supplement_1) myac072P133. DOI: 10.1093/mmy/myac072.P133.

Marand, A.J.B.; Bach, C.; Janssen, D.; Heesakkers, J.; Ghojazadeh, M.; Vögeli, T.A.; Salehi-Pourmehr, H.; Mostafae, H.; Hajebrahimi, S.; and Rahnama’i, M.S. 2021. Lower urinary tract signs and symptoms in patients with COVID-19. BMC Infect. Dis. 21(1) 706. DOI: 10.1186/s12879-021-06394-z.

Almeida, F.J.; Olmos, R.D.; Oliveira, D.B.L.; Monteiro, C.O.; Thomazelli, L.M.; Durigon, E.L.; and Sáfadi, M.A.P. 2020. Hematuria associated with SARS-CoV-2 infection in a child. Pediatr. Infect. Dis. J. 39(7) e161–e161. DOI: 10.1097/INF.0000000000002737.

Bozorgmehr, R.; and Tajabadi, Z. 2021. Hemoptysis and hematuria as the initial symptoms of COVID-19: a case report. 20(1) 75–78.


Full Text: PDF

DOI: 10.24815/jn.v25i3.46877

Refbacks

  • There are currently no refbacks.